Medical Examination and Clinical Diagnosis

Multimodal MRI⁃based neurophenotype correlated to structural bowel damage in Crohn′s disease

  • Zhuangnian FANG ,
  • Ruonan ZHANG ,
  • Lili HUANG ,
  • Xiaodi SHEN ,
  • Qingzhu ZHENG ,
  • Yangdi WANG ,
  • Xuehua LI ,
  • Zhoulei LI ,
  • Shaochun LIN
Expand
  • Department of Radiology,the First Affiliated Hospital,Sun Yat?Sen University,Guangzhou 510080,Guangdong,China

Received date: 2025-04-03

  Online published: 2025-08-11

Abstract

Objective To characterize neurological alterations associated with structural bowel damage in patients with Crohn′s disease (CD) through radiomics-assisted neurophenotyping, utilizing multiparametric brain MRI. Methods This prospective study enrolled patients with CD who underwent brain MRI, MR enterography, and ileocolonoscopy within one week. The Lémann Index was used to quantitatively assess cumulative structural bowel damage. CD patients were stratified into two groups based on a cutoff value of 4.8: those with bowel damage (LI > 4.8) and those without bowel damage (LI ≤ 4.8). A neurophenotype model was developed to characterize the neural changes associated with bowel damage in CD. Key features were selected from first-order features extracted from multiparametric brain MRI in the training cohort and validated in an independent test cohort. Results The final study population comprised 109 patients, including 51 individuals with bowel damage and 58 without bowel damage. The neurophenotype model scores were 0.785 (95%CI: 0.506 ~ 0.945) in the bowel damage group and 0.155 (95%CI: 0.093 ~ 0.394) in the non-bowel damage group, showing a statistically significant difference between the two groups (P < 0.001). The developed model exhibited strong discriminative performance, with area under the receiver operating characteristic curve (AUC) values ranging from 0.824 to 0.918 across the training, validation, and test cohorts (all P < 0.05). Conclusion Our radiomics-assisted neurophenotype analysis reveals neural alterations in CD patients with bowel damage, which may indicate extraintestinal manifestations associated with cumulative intestinal injury.

Cite this article

Zhuangnian FANG , Ruonan ZHANG , Lili HUANG , Xiaodi SHEN , Qingzhu ZHENG , Yangdi WANG , Xuehua LI , Zhoulei LI , Shaochun LIN . Multimodal MRI⁃based neurophenotype correlated to structural bowel damage in Crohn′s disease[J]. The Journal of Practical Medicine, 2025 , 41(15) : 2398 -2405 . DOI: 10.3969/j.issn.1006-5725.2025.15.016

References

[1] TORRES J, MEHANDRU S, COLOMBEL J, et al. Crohn's disease[J]. Lancet, 2017,389(10080):1741-1755. doi:10.1016/s0140-6736(16)31711-1
[2] PEYRIN-BIROULET L, LOFTUS E V J, COLOMBEL J, et al. The natural history of adult Crohn's disease in population-based cohorts[J]. Am J Gastroenterol, 2010,105(2):289-297. doi:10.1038/ajg.2009.579
[3] 何伟涛, 申晓迪, 王杨迪, 等. 基于术前磁共振小肠成像预测克罗恩病患者首次肠切除术后早期吻合口复发风险[J]. 实用医学杂志, 2024,40(5):664-671.
[4] 袁和学, 田丰, 李卉, 等. 外科治疗联合英夫利昔单抗与乌司奴单抗克对罗恩肛瘘的临床疗效观察[J]. 实用医学杂志, 2025,41(6):872-876.
[5] GRACIE D J, HAMLIN P J, FORD A C. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment[J]. Lancet Gastroenterol Hepatol, 2019,4(8):632-642. doi:10.1016/s2468-1253(19)30089-5
[6] GRACIE D J, GUTHRIE E A, HAMLIN P J, et al. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease[J]. Gastroenterology, 2018,154(6):1635-1646. doi:10.1053/j.gastro.2018.01.027
[7] ZHANG R, WANG Y, WANG H, et al. Identification of neural alterations in patients with Crohn's disease with a novel multiparametric brain MRI-based radiomics model[J]. Insights Imaging, 2024,15(1):289. doi:10.1186/s13244-024-01859-6
[8] MACER B J D, PRADY S L, MIKOCKA-WALUS A. Antidepressants in Inflammatory Bowel Disease: A Systematic Review[J]. Inflamm Bowel Dis, 2017,23(4):534-550. doi:10.1097/mib.0000000000001059
[9] De SANTIS S, MORATAL D, CANALS S. Radiomicrobiomics: Advancing Along the Gut-brain Axis Through Big Data Analysis[J]. Neuroscience, 2019,403:145-149. doi:10.1016/j.neuroscience.2017.11.055
[10] GOODYEAR B G, HEIDARI F, INGRAM R J M, et al. Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel Disease[J]. Inflamm Bowel Dis, 2023,29(3):405-416. doi:10.1093/ibd/izac089
[11] BAO C H, LIU P, LIU H R, et al. Alterations in brain grey matter structures in patients with Crohn's disease and their correlation with psychological distress[J]. J Crohns Colitis, 2015,9(7):532-540. doi:10.1093/ecco-jcc/jjv057
[12] DENG J, SUN J, LU S, et al. Exploring neural activity in inflammatory bowel diseases using functional connectivity and DKI-fMRI fusion[J]. Behav Brain Res, 2023,443:114325. doi:10.1016/j.bbr.2023.114325
[13] HUANG M, LI X, FAN W, et al. Alterations of Regional Homogeneity in Crohn's Disease With Psychological Disorders: A Resting-State fMRI Study[J]. Front Neurol, 2022,13:817556. doi:10.3389/fneur.2022.817556
[14] QIU Y, LI Q, WU D, et al. Altered mean apparent propagator-based microstructure and the corresponding functional connectivity of the parahippocampus and thalamus in Crohn's disease[J]. Front Neurosci, 2022,16:985190. doi:10.3389/fnins.2022.985190
[15] BAO C, LIU P, LIU H, et al. Differences in regional homogeneity between patients with Crohn's disease with and without abdominal pain revealed by resting-state functional magnetic resonance imaging[J]. Pain, 2016,157(5):1037-1044. doi:10.1097/j.pain.0000000000000479
[16] THAPALIYA G, ELDEGHAIDY S, ASGHAR M, et al. The relationship between Central Nervous System morphometry changes and key symptoms in Crohn's disease[J]. Brain Imaging Behav, 2023,17(2):149-160. doi:10.1007/s11682-022-00742-6
[17] GILLIES R J, KINAHAN P E, HRICAK H. Radiomics: Images Are More than Pictures, They Are Data[J]. Radiol, 2016,278(2):563-577. doi:10.1148/radiol.2015151169
[18] LI X, MAO R, HUANG S, et al. Characterization of Degree of Intestinal Fibrosis in Patients with Crohn Disease by Using Magnetization Transfer MR Imaging[J]. Radiology, 2018,287(2):494-503. doi:10.1148/radiol.2017171221
[19] PARIENTE B, TORRES J, BURISCH J, et al. Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease[J]. Gastroenterol, 2021,161(3):853-864. doi:10.1053/j.gastro.2021.05.049
[20] FIORINO G, BONIFACIO C, ALLOCCA M, et al. Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn's Disease[J]. J Crohns Colitis, 2015,9(8):633-639. doi:10.1093/ecco-jcc/jjv080
[21] MUTSAERTS H J M M, PETR J, GROOT P, et al. ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies[J]. Neuroimage, 2020,219:117031. doi:10.1016/j.neuroimage.2020.117031
[22] EMMERICH J, BACHERT P, LADD M E, et al. A novel phantom with dia- and paramagnetic substructure for quantitative susceptibility mapping and relaxometry[J]. Phys Med, 2021,88:278-284. doi:10.1016/j.ejmp.2021.07.015
[23] JORDAN K, MORIN O, WAHL M, et al. An Open-Source Tool for Anisotropic Radiation Therapy Planning in Neuro-oncology Using DW-MRI Tractography[J]. Front Oncol, 2019,9:810. doi:10.3389/fonc.2019.00810
[24] HENSCHEL L, CONJETI S, ESTRADA S, et al. FastSurfer-A fast and accurate deep learning based neuroimaging pipeline[J]. Neuroimage, 2020,219:117012. doi:10.1016/j.neuroimage.2020.117012
[25] DESIKAN R S, SéGONNE F, FISCHL B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest[J]. Neuroimage, 2006,31(3):968-980. doi:10.1016/j.neuroimage.2006.01.021
[26] LI J, LIU S, HU Y, et al. Predicting Mortality in Intensive Care Unit Patients With Heart Failure Using an Interpretable Machine Learning Model: Retrospective Cohort Study[J]. J Med Internet Res, 2022,24(8):e38082. doi:10.2196/38082
[27] VECCHIARELLI H A, AUKEMA R J, HUME C, et al. Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male Mice[J]. Front Cell Neurosci, 2021,15:764706. doi:10.3389/fncel.2021.764706
[28] FAN Y, BAO C, WEI Y, et al. Altered functional connectivity of the amygdala in Crohn's disease[J]. Brain Imaging Behav, 2020,14(6):2097-2106. doi:10.1007/s11682-019-00159-8
[29] SKROBISZ K, PIOTROWICZ G, RUDNIK A, et al. Evaluation of Subcortical Structure Volumes in Patients with Non-Specific Digestive Diseases[J]. Diagnostics (Basel), 2022,12(9): 2199. doi:10.3390/diagnostics12092199
[30] FERNANDEZ-REAL J, SERINO M, BLASCO G, et al. Gut Microbiota Interacts With Brain Microstructure and Function[J]. J Clin Endocrinol Metab, 2015,100(12):4505-4513. doi:10.1210/jc.2015-3076
Outlines

/